Axis 2
Studiedness
- Evidence amount
- 0.96
- Direction balance
- The direction of the study results has not been extracted.
- PMID records loaded
- 9
- Records after title/year deduplication
- 9
entity · release 2026-09-20
Lacticaseibacillus rhamnosus R0011
Structured fields rendered from the release dataset. Unknown values retain a reason; price is outside GIS.
Across the corpus
How this organism is actually sold
- Printed CFU per serving
- 3,569,000,000 – 7,500,000,000; median 4,640,000,000. Measured on the 4 of 10 published products carrying it whose latest published label prints a figure for it; the rest print a blend total or no quantity, and earlier label versions in the table below may print other figures. 0 row(s) print a CFU below 1 000 and are excluded as a label or parsing artefact.
- Cost per day
- $0.61 – $1.94; median $1.27. Measured on the 2 of 10 published products carrying it with an observed price and a computable days-of-supply.
- Forms
- Capsule: 8 · Powder: 2 · counted across the 10 of 10 published products whose label states a form
- Brands carrying it
- amare (1) · jarrow-formulas (3) · natural-factors (1) · nfh (3) · viva-naturals (1) · the five largest of 6 brands with a published product
- Published product pages
- 10
Products
Published products carrying this organism
| Product | Printed CFU | Printed dose | Cost per day | Form | Gut Index Score |
|---|---|---|---|---|---|
| Natural Factors ReliefBiotic IB | 4,880,000,000 | not printed | not observed | Capsule | 95.28 |
| Jarrow Formulas Jarro-Dophilus EPS 25 Billion CFU | not printed | not printed | $1.94 | Capsule | 84.03 |
| Flora Pregnancy Care Probiotic 10 Billion Cells | not printed | not printed | not observed | Capsule | 84.03 |
| NFH Recovery SAP | 7,500,000,000 | not printed | not observed | Capsule | 80.73 |
| Jarrow Formulas Jarro-Dophilus Ultra 50 Billion CFU | not printed | not printed | $0.61 | Capsule | 78.53 |
| Jarrow Formulas Jarro-Dophilus plus FOS 3.4 Billion CFU | not printed | not printed | not observed | Capsule | 72.78 |
| Amare MentaBiotics | not printed | not printed | not observed | Powder | 72.78 |
| NFH Children's ProBio SAP | 3,569,000,000 | not printed | not observed | Powder | 65.38 |
| NFH ProBio SAP | 4,400,000,000 | not printed | not observed | Capsule | 63.14 |
| Viva Naturals Probiotics for Women | not printed | not printed | not observed | Capsule | 54.44 |
Containing labels18
Evidence amount0.96
Direction balanceThe direction of the study results has not been extracted.
Matched PubMed records
9 records (retracted records excluded; 0 retracted records match the query separately). PubMed query
Matched records include trials of multi-ingredient products; this is not a count of trials of this entity alone.
- 2022 · Pathogen-Specific Effects of Probiotics in Children With Acute Gastroenteritis Seeking Emergency Care: A Randomized Trial.
- 2021 · A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.
- 2021 · Safety and Effect of a Low- and High-Dose Multi-Strain Probiotic Supplement on Microbiota in a General Adult Population: A Randomized, Double-Blind, Placebo-Controlled Study.
- 2018 · Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis.
- 2016 · Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial.
- 2016 · Calcium phosphate supplementation increases faecal Lactobacillus spp. in a randomised trial of young adults.
- 2015 · A double blind randomized trial showing probiotics to be ineffective in acute diarrhea in Indonesian children.
- 2013 · A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole.
- 2009 · Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial.
ClinicalTrials.gov
2 interventional studies. ClinicalTrials.gov query
This species has 57 tracked designations; this one appears on 18 labels (median 4).
Species and related strains
Axis 1 · inverted
Containing label versions
Showing 18 of 18 rows, ordered by Gut Index Score descending, then DSLD label ID. Download full CSV · Download full JSON.
| Brand | Product | DSLD | Gut Index Score | Strain named | Per-organism quantity | Potency basis | Versions |
|---|---|---|---|---|---|---|---|
| Natural Factors | ReliefBiotic IB | 220942 | 95.28 | true | 4,880,000,000 CFU | through expiry | 1 |
| Flora | Pregnancy Care Probiotic 10 Billion Cells | 213395 | 84.03 | true | not printed for this organism | through expiry | 1 |
| Jarrow Formulas | Jarro-Dophilus EPS 10 Billion CFU | 307627 | 84.03 | true | not printed for this organism | through expiry | 3 |
| Jarrow Formulas | Jarro-Dophilus EPS 10 Billion CFU | 307628 | 84.03 | true | not printed for this organism | through expiry | 3 |
| Jarrow Formulas | Jarro-Dophilus EPS 25 Billion CFU | 307632 | 84.03 | true | not printed for this organism | through expiry | 1 |
| NFH | Recovery SAP | 273128 | 80.73 | true | 7,500,000,000 CFU | not stated | 2 |
| NFH | Recovery SAP | 275874 | 80.73 | true | 7,500,000,000 CFU | not stated | 2 |
| Jarrow Formulas | Jarro-Dophilus Ultra 50 Billion CFU | 307629 | 78.53 | true | not printed for this organism | through expiry | 1 |
| Jarrow Formulas | Jarro-Dophilus plus FOS 3.4 Billion CFU | 307625 | 72.78 | true | not printed for this organism | not stated | 2 |
| Jarrow Formulas | Jarro-Dophilus plus FOS 3.4 Billion CFU | 307630 | 72.78 | true | not printed for this organism | not stated | 2 |
| Amare | MentaBiotics | 315563 | 72.78 | true | not printed for this organism | not stated | 1 |
| NFH | Children's ProBio SAP | 273248 | 65.38 | true | 3,569,000,000 CFU | not stated | 1 |
| NFH | ProBio SAP | 272748 | 63.14 | true | 4,400,000,000 CFU | not stated | 2 |
| NFH | ProBio SAP | 275867 | 63.14 | true | 4,400,000,000 CFU | not stated | 2 |
| Viva Naturals | Probiotics for Women | 309779 | 54.44 | true | not printed for this organism | not stated | 1 |
| Health Products Distributors | Polydophilus | 34071 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Probiology by belle + bella | Skin Therapy | 73603 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
| Jarrow Formulas | Jarro-Dophilus plus FOS 3.4 Billion CFU | 307624 | Not available in this release. | true | undefined: light snapshot | not stated | 1 |
Axis 3
Measurement integrity
Not a measurement product, so this axis does not apply.
Axis 4
Reddit mention panel
0 observed mentions; no aggregate panel matched this entity.
Elsewhere in this release
Related pages
Findings computed over the whole corpus: Strain naming census · Label designation changes · Strain dose match · Stability literature gaps
Tools: DSLD product check · Unit value calculator
Citation
Cite this page
Ivitskiy, I. (2026). Lacticaseibacillus rhamnosus R0011. Gut Registry, release 2026-09-20. Elanvale Ltd. https://gutregistry.com/s/lacticaseibacillus-rhamnosus-r0011/
The underlying tables are published under CC BY 4.0: this page as CSV · as JSON · full release and data dictionary. Cell-level provenance names the source record and its observation date.
Citable atoms
Release claims
Lacticaseibacillus rhamnosus R0011 appears on 18 of 13,330 labels in the NIH DSLD snapshot (Sep 2026), from 8 brands; tied with 5 designations by distinct label count.
18 / 13330 observed label versions · NIH DSLD snapshot Sep 2026 · entity.prevalence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324376 of 18 containing labels in the NIH DSLD snapshot (Sep 2026) print a quantity for Lacticaseibacillus rhamnosus R0011 (33.3%); 3 light records have quantities unavailable.
6 / 18 containing labels · NIH DSLD snapshot Sep 2026 · entity.quantity · checked 2026-09-20T00:00:00Z · snapshot b7633f7324379 PubMed records indexed as human randomized controlled trials match the published query (as of 2026-09-15). 9 records (retracted records excluded; 0 retracted records match the query separately).
9 / 9 loaded PMID records · NIH DSLD snapshot Sep 2026 · entity.evidence · checked 2026-09-20T00:00:00Z · snapshot b7633f7324372 interventional studies on ClinicalTrials.gov match the published query.
Published ClinicalTrials.gov query
2 / Not available in this release. interventional registry studies · NIH DSLD snapshot Sep 2026 · entity.registered_trials · checked 2026-09-20T00:00:00Z · snapshot b7633f7324373 of 14 SKUs containing Lacticaseibacillus rhamnosus R0011 have a numeric price observation (21.4%) in the release accompanying the NIH DSLD snapshot Sep 2026.
3 / 14 containing SKUs · NIH DSLD snapshot Sep 2026 · entity.price · checked 2026-09-20T00:00:00Z · snapshot b7633f732437